𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Practical approaches to minimize problems with missing quality of life data

✍ Scribed by R. John Simes; V. Greatorex; V. J. Gebski


Publisher
John Wiley and Sons
Year
1998
Tongue
English
Weight
219 KB
Volume
17
Category
Article
ISSN
0277-6715

No coin nor oath required. For personal study only.

✦ Synopsis


Missing information on quality of life (QOL) is a significant problem in many cancer trials particularly for patients with advanced disease, where clinical deterioration may be a reason for not responding to quality of life assessments. Examples from four clinical trials are presented where non-respondents to quality of life assessments have poorer health than respondents. In this context, auxiliary outcome variables, such as health status, may be useful proxies in assessing the impact of missing QOL data on estimated treatment effects. This approach is illustrated in a trial of palliative treatment in advanced cancer. A method for imputation of missing QOL data based on auxiliary outcome variables is also illustrated. However, the most effective method of minimizing the problem of missing data is in designing the trial with preventative strategies in place. Since some missing data due to deteriorating health may still occur, the design should include the collection of auxiliary QOL information. Preventative strategies are illustrated with an ongoing trial in advanced breast cancer.


πŸ“œ SIMILAR VOLUMES


Missing quality of life data in cancer c
✍ JΓΌrg Bernhard; David F. Cella; Alan S. Coates; Lesley Fallowfield; Patricia A. G πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 173 KB πŸ‘ 2 views

Measurement of quality of life (QOL) in cancer clinical trials has increased in recent years as more groups realize the importance of such endpoints. A key problem has been missing data. Some QOL data may unavoidably be missing, as for example when patients are too ill to complete forms. Other impor

Quality of life studies of the Australia
✍ Alan Coates; Val Gebski πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 143 KB πŸ‘ 2 views

The purpose of this paper is to describe the degree of compliance with quality of life measures in two clinical trials conducted by the Australian New Zealand Breast Cancer Trials Group comparing different chemotherapy policies for metastatic breast cancer. Quality of life was assessed by the patien

Why are missing quality of life data a p
✍ Diane L. Fairclough; Harriet F. Peterson; Victor Chang πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 116 KB πŸ‘ 2 views

Assessment of health related quality of life has become an important endpoint in many cancer clinical trials. Because the participants of these trials often experience disease and treatment related morbidity and mortality, non-random missing assessments are inevitable. Examples are presented from se

Statistical analysis of quality of life
✍ Andrea B. Troxel; Diane L. Fairclough; Desmond Curran; Elizabeth A. Hahn πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 255 KB πŸ‘ 2 views

We summarize issues that arise when considering quality of life (QOL) data in cancer clinical trials, especially those related to missing data. We describe different types of missing data mechanisms, and discuss ways of assessing and testing missing data mechanisms. A section on presentation of stud

Quality of life assessment in Internatio
✍ JΓΌrg Bernhard; Harriet F. Peterson; Alan S. Coates; Heidi Gusset; Mary Isley; Ri πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 179 KB πŸ‘ 2 views

We report on our experience of quality of life (QL) assessment in adjuvant clinical trials of the International Breast Cancer Study Group (IBCSG), with special emphasis on cultural and logistical aspects of international organization that are unique to this group. Data are presented regarding submis

Missing data in quality of life research
✍ Elizabeth A. Hahn; Kimberly A. Webster; David Cella; Diane L. Fairclough πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 177 KB πŸ‘ 2 views

Incorporation of quality of life (QOL) investigation into Eastern Cooperative Oncology Group (ECOG) multi-centre clinical trials has led to innovative strategies for protocol design and high quality data collection. A scientific advisory committee reviews protocol design components, measurement sele